UPDATE: Aranesp, Procrit and Epogen lawsuits no longer being reviewed
Saiontz, Kirk & Miles, P.A. will not be reviewing any new lawsuits for users of anemia drugs who have suffered problems as a result of Aranesp, Procrit and Epogen side effects. The decision comes after two months of carefully reviewing the potential claims. Although there appears to be evidence that the manufacturers placed profits before the safety of their consumers, at this time we are unable to review any new claims given the complex issues regarding causation for each individual claimant.
Aranesp (darbepoetin alfa), Procrit (epoetin alfa) and Epogen (epoetin alfa) are injections administered to treat anemia associated with dialysis for those with kidney failure and chemotherapy in cancer patients. When given at high doses, the anemia injection side effects have been found to increase the risk of blood clots, strokes, heart attacks and death. They have also been linked to an increased rate of tumor growth when given to those with certain types of cancer.
>>MORE INFORMATION: Anemia injection side effects
The decision to move forward with any legal claim for a defective product or medication involves significant research and investigation. Although we will continue to monitor the potential for these lawsuits in the future, we will not be reviewing any new claims or represent any individuals with regard to problems associated with these drugs. If there is any change in the status of the investigation of Aranesp, Procrit and Epogen lawsuits, information will be posted here.
>>SUBSCRIBE TO LEGAL NEWS AND UPDATES: Receive alerts by Email
RSS Feed
Saiontz, Kirk & Miles is a national law firm which handles a variety of serious personal injury claims, including medical malpractice, cerebral palsy birth injuries, nursing home neglect and defective products. Some of the defective medications and medical products we are currently investigating and pursuing lawsuits on behalf of clients nationwide include:
-
Plavix: side effects include GI bleeds, ulcers, heart attacks, strokes and TTP blood disorders
-
Drug Eluting Stents: problems include blood clots and heart attacks
-
Fosamax: jaw osteonecrosis
-
Ketek: liver damage
-
Zelnorm: recalled due to risk of heart attacks, strokes and death
-
Hernia repair mesh: recall as a result of bowel perforation and chronic intestinal fistula







